Email updates

Keep up to date with the latest news and content from Retrovirology and BioMed Central.

This article is part of the supplement: AIDS Vaccine 2012

Open Access Poster presentation

Limited evidence for alterations in Gag-mediated HIV replication capacity over the course of the North American epidemic (1979-present)

L Cotton1*, D Chopera1, K Penney1, J Carlson2, E Martin1, A Le1, T Kuang1, B Walker3, J Fuchs4, S Buchbinder4, T Wagner4, M John5, S Mallal5, B Koblin6, K Mayer7, A Poon8, M Brockman1 and Z Brumme1

  • * Corresponding author: L Cotton

Author Affiliations

1 Simon Fraser University, Burnaby, Canada

2 Microsoft Research, Los Angeles, CA, USA

3 Ragon Institute, Charlestown, MA, USA

4 San Francisco Dept of Public Health, San Francisco, CA, USA

5 Murdoch University, Perth, Australia

6 New York Blood Center, New York, NY, USA

7 Fenway Community Health, Boston, MA, USA

8 BC Centre for Excellence in HIV/AIDS, Vancouver, Canada

For all author emails, please log on.

Retrovirology 2012, 9(Suppl 2):P157  doi:10.1186/1742-4690-9-S2-P157

The electronic version of this article is the complete one and can be found online at: http://www.retrovirology.com/content/9/S2/P157


Published:13 September 2012

© 2012 Cotton et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Background

The extent to which HIV replication capacity (RC) has changed over the epidemic’s course, and the influence of HLA-associated immune pressure as its driving force remains unknown. We performed a comparative study of immune escape and RC in historic (1979-1989) and modern Gag subtype B sequences from North America.

Methods

Using phylogenetically-informed methods, we identified HLA-associated Gag polymorphisms in a historic cohort (N=239; 1979-1989). We also generated recombinant NL4-3 viruses encoding clonal plasma RNA Gag from 80 historic and 58 modern (2002-2008) sequences. Viral RC was measured using a GFP reporter T-cell assay and results were normalized to NL4-3 controls.

Results

95% of HLA-associated polymorphisms identified in the historic cohort were consistent with published modern escape pathways. Overall, the prevalence of HLA-associated polymorphisms in the general population increased a median 1.3-fold between historic and modern sequences; however in many cases this was influenced by differences in HLA allele frequencies between HIV-infected populations examined. Of note, the prevalence of the B*27-associated R264K escape mutation increased from 0.4 to 1.3% in the general population over time despite B*27 allele frequency remaining constant at 2.5%. Modestly lower viral RC was observed for Gag recombinant viruses constructed from pre-1985 sequences (median 0.86 [IQR 0.78-0.97], N=24) compared to those from 1985-1989 (median 0.98 [IQR 0.87-1.05], N=56) and 2002-2008 (median 0.96 [IQR 0.83-0.1.10], N=58) (p=0.049). In both historic and modern cohorts, host expression of HLA-B*27 was associated with lower RC (p=0.007). Gag codons associated with lower RC, including S67A, were identified in an exploratory analysis.

Conclusion

Gag-mediated viral RC may have increased modestly since the beginning of the North American epidemic, despite limited evidence for HLA-driven viral sequence evolution during this time. Although mechanisms driving RC differences remain unclear, results do not support rapid and substantial accumulation of HLA-driven escape mutations in circulating North American HIV-1 sequences.